Currently beta-adrenergic receptor blockers are considered to be potential drugs under investigation for preventive or therapeutic effect in osteoporosis.
Bhat, MR +3 more
core +1 more source
In früheren Studien wurde festgestellt, dass soluble Klotho (sKl) ein Prädiktor für Nierenschädigungen und chronische Nierenerkrankungen (CKD) ist.
Steinringer, Stefan
core
Modern views on the etiology, pathogenesis, diagnosis, prevention and treatment of vitamin D deficiency in postmenopausal women (literature review) [PDF]
In the literary review is presented the modern data showing different forms of vitamin D deficiency and its optimal ways of correction. It specifies the pathway of vitamin D in the body.
T Yu Pestrikova, T V Yachinskaya
doaj
5/6 Nx = 5/6 nephrectomy, Ctrl = control, CRF = chronic renal failure, HP = high phosphate, NP = normal phosphate, D = alfacalcidol, ICG = ICG-001, Veh = Vehicle, 8w = 8weeks. After four weeks of uremia CRF rats were allocated to five experimental groups
Carsten Nielsen (5593808) +8 more
core +1 more source
The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study [PDF]
BACKGROUND: The risk of cardiovascular disease is tremendously high in dialysis patients. Dialysis patients treated with vitamin D analogs show decreased cardiovascular morbidity and mortality compared with untreated patients.
Bruunsgaard, H. +14 more
core +2 more sources
Prophylactic Use of Alfacalcidol in Corticosteroid-Induced Osteoporosis
peer reviewedOne hundred and forty-five patients suffering from diseases requiring long-term treatment with high doses of corticosteroids (30 mg/day or greater of prednisolone) were recruited to the study. Patients had to be steroid naive on entry to the
Menkes, C. J. +6 more
core +1 more source
Alendroninezuur effectiever dan alfacalcidol voor preventie van osteoporose bij patiënten met een reumatische ziekte die starten met glucocorticoïdtherapie [PDF]
OBJECTIVE: To compare the effects of alendronate and alfacalcidol in the prevention ofglucocorticoid-related osteoporosis in patients with a rheumatic disease. DESIGN: Randomised, double-blind, double-placebo clinical trial (www.
Buskens, E.; id_orcid +12 more
core +3 more sources
AIM: To evaluate the efficacy and safety of alfacalcidol and paracalcitol used to correct impaired phosphorus-calcium metabolism (PCM) in patients with predialysis chronic kidney disease (CKD)/MATERIAL AND METHODS: Examinations were made in 128 patients ...
L Iu Milovanova +2 more
doaj
Differences of therapeutic effects on regional bone mineral density and markers of bone mineral metabolism between alendronate and alfacalcidol in Japanese osteoporotic women [PDF]
We studied the differences of therapeutic effects on regional bone mineral density (BMD) and markers of bone mineral metabolism between alendronate and alfacalcidol in Japanese osteoporotic women.
Yasui, Natsuo +12 more
core
Diagram of the experimental protocol.
OLETF rats were assigned to each treatment group. Each treatment began at the age of 20 weeks. OLETF = Otsuka Long-Evans Tokushima Fatty; LETO = Long-Evans Tokushima Otsuka (non-diabetic control); Cont = control (diabetic control); ALF = alfacalcidol ...
Yusuke Yuasa (5866529) +10 more
core +1 more source

